Literature DB >> 26519524

Effect of acetaminophen on sulfamethazine acetylation in male volunteers.

I M Tahir1, T Iqbal2, S Saleem3, H Mehboob2, N Akhter4, M Riaz2.   

Abstract

The effect of acetaminophen on sulfamethazine N-acetylation by human N-acetyltrasferase-2 (NAT2) was studied in 19 (n=19) healthy male volunteers in two different phases. In the first phase of the study the volunteers were given an oral dose of sulfamethazine 500 mg alone and blood and urine samples were collected. After the 10-day washout period the same selected volunteers were again administered sulfamethazine 500 mg along with 1000 mg acetaminophen. The acetylation of sulfamethazine by human NAT2 in both phases with and without acetaminophen was determined by HPLC to establish their respective phenotypes. In conclusion obtained statistics of present study revealed that acetaminophen significantly (P<0.0001) decreased sulfamethazine acetylation in plasma of both slow and fast acetylator male volunteers. A highly significant (P<0.0001) decrease in plasma-free and total sulfamethazine concentration was also observed when acetaminophen was co-administered. Urine acetylation status in both phases of the study was found not to be in complete concordance with that of plasma. Acetaminophen significantly (P<0.0001) increased the acetyl, free and total sulfamethazine concentration in urine of both slow and fast acetylators. Urine acetylation analysis has not been found to be a suitable approach for phenotypic studies.
© The Author(s) 2015.

Entities:  

Keywords:  N-acetyltransferase 2 (NAT2); Pakistan; acetaminophen; acetyl sulfamethazine (AcSMZ); acetylation; slow and fast acetylator; sulfamethazine (SMZ)

Mesh:

Substances:

Year:  2015        PMID: 26519524      PMCID: PMC5806733          DOI: 10.1177/0394632015593238

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  23 in total

1.  Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.

Authors:  D M Grant; K Mörike; M Eichelbaum; U A Meyer
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  How personalized medicine became genetic, and racial: Werner Kalow and the formations of pharmacogenetics.

Authors:  David S Jones
Journal:  J Hist Med Allied Sci       Date:  2011-09-10       Impact factor: 2.088

3.  N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.

Authors:  Azza M Kamel; Gamal T A Ebid; Heba S Moussa
Journal:  Tumour Biol       Date:  2015-03-25

4.  Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: no activity of isoniazid in the continuation phase.

Authors:  C M Tam; S L Chan; K M Kam; E Sim; D Staples; K M Sole; H Al-Ghusein; D A Mitchison
Journal:  Int J Tuberc Lung Dis       Date:  2000-03       Impact factor: 2.373

5.  Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells.

Authors:  N J Butcher; K F Ilett; R F Minchin
Journal:  Mol Pharmacol       Date:  2000-03       Impact factor: 4.436

Review 6.  Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.

Authors:  Jason M Walraven; Yu Zang; John O Trent; David W Hein
Journal:  Curr Drug Metab       Date:  2008-07       Impact factor: 3.731

7.  Acetylation of sulfamethazine in a Nigerian population.

Authors:  L C Eze; O Obidoa
Journal:  Biochem Genet       Date:  1978-12       Impact factor: 1.890

Review 8.  PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.

Authors:  Ellen M McDonagh; Sotiria Boukouvala; Eleni Aklillu; David W Hein; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-08       Impact factor: 2.089

9.  Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 in vitro and in vivo.

Authors:  J P Rothen; W E Haefeli; U A Meyer; L Todesco; M Wenk
Journal:  Pharmacogenetics       Date:  1998-12

10.  NAT2 genetic variations among South Indian populations.

Authors:  Saikrishna Lakkakula; Ram Mohan Pathapati; Gyaneshwer Chaubey; Arasambattu Kannan Munirajan; Bhaskar Vks Lakkakula; Rajasekhar Maram
Journal:  Hum Genome Var       Date:  2014-10-02
View more
  2 in total

Review 1.  Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions.

Authors:  Aben Ovung; Jhimli Bhattacharyya
Journal:  Biophys Rev       Date:  2021-03-29

2.  Effect of UDP-Glucuronosyltransferase (UGT) 1A Polymorphism (rs8330 and rs10929303) on Glucuronidation Status of Acetaminophen.

Authors:  Huma Mehboob; Imtiaz Mahmood Tahir; Tahira Iqbal; Sadaf Saleem; Sofia Perveen; Aboubakker Farooqi
Journal:  Dose Response       Date:  2017-09-11       Impact factor: 2.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.